Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

PROTEINUDSALG ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   3.6% 3.6% 3.6% 3.6% 3.6% 3.6% 3.6% 3.6%   Bankruptcy risk   18.0% 32.7% 10.9% 10.8% 6.1% 5.6% 11.4% 11.2%   Credit score (0-100)   9 1 21 22 37 41 21 22   Credit rating   B C BB BB BBB BBB BB BB   Credit limit (kDKK)   0.0 -0.0 -0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   840 1,064 0 0 0 0 0 0   Gross profit   199 29.4 155 582 699 390 0.0 0.0   EBITDA   26.4 -115 -16.3 446 444 104 0.0 0.0   EBIT   26.4 -115 -16.3 446 444 104 0.0 0.0   Pre-tax profit (PTP)   19.4 -134.2 -38.9 430.4 435.3 99.4 0.0 0.0   Net earnings   19.4 -134.2 -38.9 355.5 327.3 76.5 0.0 0.0   Pre-tax profit without non-rec. items   19.4 -134 -38.9 430 435 99.4 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -27.0 -161 -160 270 598 674 634 634   Interest-bearing liabilities   4.7 0.0 0.0 29.6 0.0 2.3 0.0 0.0   Balance sheet total (assets)   313 321 370 978 1,232 1,170 634 634   Net Debt   -6.5 -39.0 -67.8 -283 -380 -384 -634 -634     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   840 1,064 0 0 0 0 0 0   Net sales growth   11.2% 26.7% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   199 29.4 155 582 699 390 0.0 0.0   Gross profit growth   81.1% -85.2% 426.0% 276.1% 20.1% -44.2% -100.0% 0.0%   Employees   0 0 3 2 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% -33.3% -50.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   313 321 370 978 1,232 1,170 634 634   Balance sheet change%   92.3% 2.5% 15.2% 164.5% 26.0% -5.0% -45.8% 0.0%   Added value   26.4 -114.8 -16.3 445.7 444.1 103.5 0.0 0.0   Added value %   3.1% -10.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   3.0 4.0 -1.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 -2.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   3.1% -10.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   3.1% -10.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   13.3% -390.2% -10.5% 76.6% 63.5% 26.5% 0.0% 0.0%   Net Earnings %   2.3% -12.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   2.3% -12.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   2.3% -12.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   9.6% -27.9% -3.2% 59.1% 40.2% 8.7% 0.0% 0.0%   ROI %   1,127.3% -4,897.1% 0.0% 297.1% 98.9% 16.4% 0.0% 0.0%   ROE %   8.1% -42.3% -11.3% 111.1% 75.4% 12.0% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   -7.9% -33.4% -30.2% 27.7% 48.5% 57.6% 100.0% 100.0%   Relative indebtedness %   40.5% 45.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   39.2% 41.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -24.5% 33.9% 417.4% -63.6% -85.7% -370.7% 0.0% 0.0%   Gearing %   -17.4% 0.0% 0.0% 10.9% 0.0% 0.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   301.0% 829.5% 0.0% 103.3% 59.5% 456.4% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.0 0.1 0.1 0.5 0.6 0.8 0.0 0.0   Current Ratio   0.9 0.7 0.7 1.4 1.8 2.2 0.0 0.0   Cash and cash equivalent   11.2 39.0 67.8 313.1 380.4 386.1 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   37.1% 30.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -28.9 -163.1 -160.1 270.4 527.5 598.5 0.0 0.0   Net working capital %   -3.4% -15.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 -5 223 444 104 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 -5 223 444 104 0 0   EBIT / employee   0 0 -5 223 444 104 0 0   Net earnings / employee   0 0 -13 178 327 77 0 0